Inventor · disambiguated record
Frederick O. Cope
Also filed as: COPE FREDERICK O · COPE FREDERICK OLIVER
16 granted patents·20 pending applications·532 citations·filing 1993–2025
94Inventor score
Files withABBOTT LAB10CARDINAL HEALTH 414 LLC8NAVIDEA BIOPHARMACEUTICALS INC8PHYSIS INT LLC3COPE FREDERICK O2
Top patents by PatentIndex Score
36 records- 0197US6326355B1Method for the prevention and treatment of cachexia and anorexiaABBOTT LAB·Filed 2000·Granted Dec 4, 2001·134 cites·13 claims
- 0294US6387883B1Method for the prevention and treatment of cachexia and anorexiaABBOTT LAB·Filed 2000·Granted May 14, 2002·45 cites·18 claims
- 0391US6077828AMethod for the prevention and treatment of cachexia and anorexiaABBOTT LAB·Filed 1997·Granted Jun 20, 2000·67 cites·20 claims
- 0490US11007272B1Compounds and methods for diagnosis and treatment of viral infectionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2017·Granted May 18, 2021·6 cites·12 claims
- 0583US5547927AEnteral nutritional product for patients undergoing radiation therapy and/or chemotherapyABBOTT LAB·Filed 1993·Granted Aug 20, 1996·51 cites·19 claims
- 0681US11369680B2Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using sameNAVIDEA BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 28, 2022·2 cites·11 claims
- 0779US5700782AEnteral nutritional productABBOTT LAB·Filed 1995·Granted Dec 23, 1997·71 cites·19 claims
- 0877US5514656AMethod of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapyABBOTT LAB·Filed 1993·Granted May 7, 1996·40 cites·19 claims
- 0977US2025228985A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameCARDINAL HEALTH 414 LLC·Filed 2025·Application pending·0 cites
- 1076US5403826ANutritional product for persons infected with human immunodeficiency virusABBOTT LAB·Filed 1993·Granted Apr 4, 1995·36 cites·20 claims
- 1174US5330972AMethod of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virusABBOTT LAB·Filed 1993·Granted Jul 19, 1994·47 cites·16 claims
- 1274US2022062448A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameCARDINAL HEALTH 414 LLC·Filed 2021·Application pending·0 cites
- 1373US2023218783A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameCARDINAL HEALTH 414 LLC·Filed 2021·Application pending·0 cites
- 1472US2021275698A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameCARDINAL HEALTH 414 LLC·Filed 2020·Application pending·0 cites
- 1570US12005122B2Compounds and methods for diagnosis and treatment of viral infectionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2021·Granted Jun 11, 2024·0 cites·20 claims
- 1666US7223736B2Composition for the prevention and treatment of cachexiaABBOTT LAB·Filed 2004·Granted May 29, 2007·1 cites·6 claims
- 1766US5480872AMethod of providing enternal nutritional support to persons infected with human immunodeficiency virusABBOTT LAB·Filed 1993·Granted Jan 2, 1996·32 cites·20 claims
- 1863US2016206763A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameNAVIDEA BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1963US2007196445A1Method for the Prevention and Treatment of Cachexia and AnorexiaABBRUZZESE BONNIE C·Filed 2007·Application pending·0 cites
- 2062US2012270826A1Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditionsCOPE FREDERICK O·Filed 2012·Application pending·0 cites
- 2162US2018015187A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameCARDINAL HEALTH 414 LLC·Filed 2015·Application pending·0 cites
- 2261US2021338848A1Compositions and methods for diagnosing and treating macrophage-related disorders using carbohydrate-based macromolecular carrierCARDINAL HEALTH 414 LLC·Filed 2020·Application pending·0 cites
- 2361US2010003674A1Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditionsCOPE FREDERICK O·Filed 2008·Application pending·0 cites
- 2459US2022016272A1Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disordersCARDINAL HEALTH 414 LLC·Filed 2021·Application pending·0 cites
- 2557US12070504B1Compounds and methods for altering cyto-states of cells that express c-type lectin receptorsPHYSIS INT LLC·Filed 2022·Granted Aug 27, 2024·0 cites·16 claims
- 2656US2018092998A1Compositions and methods for diagnosing and treating macrophage-related disorders using carbohydrate-based macromolecular carrierCARDINAL HEALTH 414 LLC·Filed 2017·Application pending·0 cites
- 2755US2013345289A1Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditionsCOPE FREDERICK OLIVER·Filed 2013·Application pending·0 cites
- 2853US11497763B1Compounds and methods for treating and diagnosing RNA virus infectionsPHYSIS INT LLC·Filed 2021·Granted Nov 15, 2022·0 cites·9 claims
- 2953US2020237937A1Compositions and methods for assessing macrophage mediated pathologyNAVIDEA BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3053US2002099020A1Method for the prevention and treatment of cachexia and anorexiaFiled 2001·Application pending·0 cites
- 3152US2015023876A1Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disordersNAVIDEA BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3248US2019022259A1Use of 99mTc-tilmanocept and related molecular constructs for identifying and diagnosing malignant tumors and for monitoring therapeutic anti-tumor interventionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3344US2019021608A1CD206+ Macrophage-Specific Molecular Imaging Probe Compositions and Methods and the Noninvasive Quantification of Arterial Wall Macrophage Infiltration in HumansNAVIDEA BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3443US10806803B2Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosisOHIO STATE INNOVATION FOUNDATION·Filed 2015·Granted Oct 20, 2020·0 cites·11 claims
- 3543US2005036972A1System for managing pathogens and irritants and monitoring usage of anti-bacterial formulationsHY GENE BIOMEDICAL CORP·Filed 2004·Application pending·0 cites
- 3643US2025242038A1Compounds and methods for the elimination of living vertebrate tissuePHYSIS INT LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederick O. Cope files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →